Blog

Protect executive talent with supplemental disability insurance that closes income gaps, strengthens retention, and enhances recruiting efforts.

In 2026, employers are confronting a growing challenge that extends well beyond traditional retirement planning: escalating financial stress across the workforce, particularly among younger employees. This pressure is fundamentally reshaping how organizations structure benefits and how retirement plans must evolve to remain relevant, supportive, and competitive.

The rising demand for GLP-1 medications — widely recognized for their effectiveness in weight management and chronic disease prevention — has created a significant coverage gap in Medicare.

As a reminder, ERISA requires employer plan sponsors/administrators to deliver ERISA required documents and other notices (hereinafter referred to collectively as “covered documents1”) to plan participants and beneficiaries in a manner “reasonably calculated to ensure actual receipt.”

Explore 2026 pharmacy benefit trends, including GLP-1s, biosimilars, oncology therapies, and new FDA-approved drugs.

Check out the July 2026 edition of our monthly Newsletter. This newsletter is brought to you by eBen and Risk Strategies.